Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The American Diabetes Association (ADA) recommends GLP-1 RAs in patients with clinical characteristics like presence of established ASCVD and cardiac heart failure or chronic kidney diseases [15]
New England Journal of Medicine, 387(24), 22452257
However, in the exenatide treatment group, the primary outcome rate was 61.2% (n=170), compared to 56.7% in the standard treatment group (n=171), with an adjusted ratio of 1.22 [95% CI, 0.79-1.88] (P=0.38)., which meant that the proportion of subjects who achieved the desired effect in exenatide treatment group was higher (110)
For longer-lasting results, its generally recommended to maintain a healthy lifestyle with proper sun protection and follow-up treatments as advised by our providers
What does GLP-1 cost at LIVation
US$ 24.93
US$ 25.63
US$ 25.72
